
The top news stories in primary care today.

The top news stories in primary care today.


Everything you need to know about annuities

Register today for the free Medical Economics Practice Academy, scheduled for today, June 29.

31% of physicians get sued during their careers

Technology has potential to improve provider efficiency and patient outcomes

Patients deserve our respect no matter the circumstances

Fewer clinic hours may lead to less burnout, but physicians still spend time outside work filling in notes.

Register today for the free Medical Economics Practice Academy, scheduled for Thursday, June 29.

Commonwealth Fund’s 2023 scorecard ranks 50 states and District of Columbia.

The American population is aging and could benefit from moving more and building muscle.

Concierge medicine offers an optimal environment for treating chronic disease


U.S. Census Bureau figures show the graying of America, but some counties have populations at least half younger than 30.

Study points to need for interventions tailored to race and gender

Register today for the free Medical Economics Practice Academy, scheduled for Thursday, June 29.

Finding may have implications as more people take care of aging relatives around the world.

Pre-pandemic levels still prove elusive as hospitals look for new strategies

Study examines prices of 8 procedures and finds other characteristics when doctors are owners.



Also in Washington, physicians and MedPAC back site-neutral payment for in-person care.

Report shows that health care employees are struggling thanks to poor company policies and training content.

Register today for the free Medical Economics Practice Academy, scheduled for Thursday, June 29.

As number of deaths climbed, medications were not used evenly around the states, according to a new study.

How one medical practice is growing and expanding with the help of a third-party vendor.

The top news stories in primary care today.

The latest health care technology news.

NIDA study shows significant gender difference, but reasons are uncertain

FDA approves Jardiance and Synjardy for pediatric use.